Fateme Babaha: Pleasure to Present A Novel FVIII Gene Therapy Enhancer at ISTH 2026
Fateme Babaha, PhD in Pathology and Molecular Medicine at Queen’s University, shared on LinkedIn:
”It was a pleasure to present my research at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris!
It had the opportunity to present my work, ‘Efficacy of AAV-mediated FVIII transgene expression employing a short enhancer element from the human F8 locus,’ and to connect with researchers and experts in the field of hemophilia and gene therapy.
In this study, we investigated a novel, compact 92-bp enhancer element from the human F8 locus and its potential to improve FVIII transgene expression for hemophilia A gene therapy.
I’m grateful to my supervisor Dr. David Lillicrap for his continued support and to everyone who stopped by my poster for the insightful discussions and questions.”
Stay updated with Hemostasis Today.
-
Oct 29, 2026, 23:09Brad Flora: Reaching 15 Gallons of Lifetime Blood Donations
-
Oct 29, 2026, 23:07David McIntosh: Why We Need Thousands of Blood Donations Every Day
-
Oct 29, 2026, 23:07Tamer El-Sayed: Could Anaemia Be an Overlooked Factor in Patients with Intermittent Claudication?
-
Oct 29, 2026, 23:05Sakditad Saowapa: AF and Cancer From Shared Biology to Anticoagulation Challenges
-
Oct 29, 2026, 23:03Sabina Ali: The SToP Curriculum for Venous Thromboembolism Prevention in Pediatric IBD
-
Oct 29, 2026, 21:50Dave Cartland: Comparing Cerebral Thromboembolism Reports After COVID-19 and Influenza Vaccination
-
Oct 29, 2026, 16:39A Scholarship Creating Opportunities for Women with Bleeding Disorders – WFH
-
Oct 29, 2026, 16:30Wendy Disbro: AABB Highlights the People and Experience Behind Transfusion Medicine
-
Oct 29, 2026, 16:23Reza Shojaei: Artificial Intelligence in Blood Donation